(CLCS) – PRNewswire
-
Darlene Soave Joins Cell Source's Board of Directors
-
USPTO Issues New Patents for Cell Source's Veto Cell Technology
-
Veto T-Cell Bone Marrow Transplant Safely Demonstrates Potential Cure for Sickle Cell Anemia in Preclinical Trials
-
Pediatric Stem Cell Transplantation Expert and Industry Leader Dr. Joseph Rosenthal Joins Cell Source's Scientific Advisory Board
Back to CLCS Stock Lookup